Return to Search
Intravenous Immune Globulin
Guidance for the he Medicare Prescription Drug, Improvement, and Modernization Act of 2003, as of January 1, 2004, that covers intravenous immune globulin in the home for the treatment of primary immune deficiency diseases.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 23, 2004
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.